✦ LIBER ✦

Oxidatively modified proteins in Alzheimer’s disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis

✍ Scribed by Rukhsana Sultana; Marzia Perluigi; D. Allan Butterfield

Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 799 KB
Volume: 118
Category: Article
ISSN: 0001-6322
DOI: 10.1007/s00401-009-0517-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of the slopes of cognitive im

Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl)

✍ M.D. Campanozzi; E. Casali; F. Neviani; E. Martini; M. Neri 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 843 KB

Alterations in zinc transporter protein-

Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage alzheimer’s disease

✍ Mark A. Lovell; Jennifer L. Smith; Shuling Xiong; William R. Markesbery 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 376 KB

Effect of Ultralow Doses of Antibodies t

Effect of Ultralow Doses of Antibodies to S-100 Protein in Animals with Impaired Cognitive Function and Disturbed Emotional and Neurological Status under Conditions of Experimental Alzheimer Disease

✍ T. A. Voronina; M. V. Belopol’skaya; I. A. Kheyfets; Yu. L. Dugina; S. A. Sergee 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 128 KB

Decreased levels of PSD95 and two associ

Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Aβ, and neurodegeneration in a prodromal stage of Alzheimer's disease

✍ Rukhsana Sultana; William A. Banks; D. Allan Butterfield 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

## Abstract Alzheimer's disease (AD) is the most common form of dementia and is pathologically characterized by senile plaques, neurofibrillary tangles, synaptic disruption and loss, and progressive neuronal deficits. The exact mechanism(s) of AD pathogenesis largely remain unknown. With advances i